BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 5519106)

  • 1. [Prevention of development of the bacterial carrier state through vaccine-antibiotic therapy of patients with typhoid and paratyphoid. 1. Pecularities of the course of thyphoid and paratyphoid in the complex therapy of patients with levomycetin and dry alcoholic typhoid-paratyphoid B divaccine].
    Bilibin AF; Musabaev IK; Medvedev AS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):107-12. PubMed ID: 4965909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complex therapy of intestinal infectious diseases--a basis of prophylaxis of bacterial carrier state].
    Bunin KV
    Klin Med (Mosk); 1974; 52(8):37-41. PubMed ID: 4423436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of patients with typhoid and paratyphoid fever by use of typhoid-paratyphoid B vaccines with the aim of prevention of carrier state formation].
    Bilibin AF; Kornilova II; Antonova IV; Kilesso VA; Riadneva OE; Taratorina OM; Izmaĭlova NB; Khazanova LE
    Klin Med (Mosk); 1965 Aug; 43(8):112-7. PubMed ID: 4957973
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of bacterial carrier state in typhoid and paratyphoid patients by means of antibiotic-vaccineotherapy. II. The dynamics of immunologic indices in typhoid and paratyphoid patients treated with levomycetin and dry alcoholic typho-paratyphoid B divaccine].
    Tendetnik IuIa; Kilesso VA; Vydrina EI; Leĭtman MZ; Taratorina OM
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):73-80. PubMed ID: 4978572
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic basis for typhoid carrier state formation and methods of prevention].
    Bunin KV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):5-10. PubMed ID: 5519106
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunobiological aspects of the typhoid bacteria carrier state (a review of the literature)].
    Bilibin AF; Khundanov LL
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):9-17. PubMed ID: 4615523
    [No Abstract]   [Full Text] [Related]  

  • 7. [Typhoid fever--paratyphoid fever].
    Nagatake T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):486-9. PubMed ID: 10088452
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogenesis of the typhoid bacterium carrier state].
    Obgol'ts AA; Dalmatov DM
    Sov Med; 1986; (4):54-7. PubMed ID: 3520873
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanisms of protection in the pathogenesis of the typhoid bacterial carrier state].
    Obgol'ts AA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Aug; (8):98-103. PubMed ID: 6195845
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Typhoid fever: pathogenesis and immunologic control.
    Hornick RB; Greisman SE; Woodward TE; DuPont HL; Dawkins AT; Snyder MJ
    N Engl J Med; 1970 Sep; 283(13):686-91. PubMed ID: 4916913
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.